Revision history of "Epigenetic mechanisms of resistance to castration in prostate cancer: therapeutic opportunities in combination with androgen receptor antagonists." (Q3137594)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 23:5723:57, 8 October 2024DG Regio talk contribs 78,880 bytes +2 Changed label, description and/or aliases in pt
  • curprev 23:5723:57, 8 October 2024DG Regio talk contribs 78,878 bytes 0 Set a claim value: summary (P836): A resistência terapêutica representa a principal causa de morte por cancro e despesas farmacêuticas nos cuidados oncológicos. A investigação dos mecanismos celulares e moleculares associados à aquisição de resistência é de vital importância para a gestão clínica dos doentes e na gestão dos recursos dos sistemas públicos de saúde. O cancro da próstata é paradigmático desta situação; enquanto a sobrevivência de 5 anos de doentes com tumores em fase in...

12 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 06:3206:32, 4 August 2022DG Regio talk contribs 77,590 bytes +53,293 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 09:2809:28, 2 December 2021DG Regio talk contribs 15,946 bytes +2,760 Created claim: summary (P836): La résistance thérapeutique représente la principale cause de décès par cancer et les dépenses pharmaceutiques dans les soins anticancéreux. La recherche des mécanismes cellulaires et moléculaires associés à l’acquisition de la résistance est d’une importance vitale pour la prise en charge clinique des patients et pour la gestion des ressources des systèmes de santé publique. Le cancer de la prostate est paradigmatique de cette situation; alors...
  • curprev 09:2809:28, 2 December 2021DG Regio talk contribs 13,186 bytes +251 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 12:3512:35, 12 October 2021DG Regio talk contribs 12,935 bytes +206 Changed label, description and/or aliases in en: translated_label
  • curprev 12:3512:35, 12 October 2021DG Regio talk contribs 12,729 bytes +2,402 Created claim: summary (P836): Therapeutic resistance represents the leading cause of cancer death and pharmaceutical expenditure in cancer care. Researching the cellular and molecular mechanisms associated with the acquisition of resistance is of vital importance for the clinical management of patients and in the management of resources of public health systems. Prostate cancer is paradigmatic of this situation; while 5-year survival of patients with early-stage tumors is ab...

10 October 2021

9 October 2021

7 October 2021